PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Mechanism of action
Clinical evidence
Tuber extracts demonstrated in vitro inhibitory effects on pancreatic lipase (IC50 = 381.86 μg/ml), alpha-glucosidase (IC50 = 157.99 μg/mL), and alpha-amylase (IC50 = 439.45 μg/ml) [PMID:30294692]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 29791313 (2018) — Acute and subacute toxicity of aqueous extract of the tuber of Kedrostis africana (L.) Cogn in Wistar rats. · Journal of complementary & integrative medicine
- 2.PMID: 30294692 (2018) — In vitro α-amylase, α-glucosidase, lipase inhibitory and cytotoxic activities of tuber extracts of Kedrostis africana (L.) Cogn. · Heliyon